共 209 条
[1]
Dohner H(2015)Acute myeloid leukemia N Engl J Med 373 1136-1152
[2]
Weisdorf DJ(2016)The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia Blood 127 2391-2405
[3]
Bloomfield CD(2016)Genomic classification and prognosis in acute myeloid leukemia N Engl J Med 374 2209-2221
[4]
Arber DA(2015)Simpson’s paradox and the impact of different DNMT3A mutations on outcome in younger adults with acute myeloid leukemia J Clin Oncol 33 2072-2083
[5]
Orazi A(2016)Evaluation of DNMT3A genetic polymorphisms as outcome predictors in AML patients Oncotarget. 7 60555-60574
[6]
Hasserjian R(1992)Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia Blood 79 313-319
[7]
Thiele J(2014)Combined molecular and clinical prognostic index for relapse and survival in cytogenetically normal acute myeloid leukemia J Clin Oncol 32 1586-1594
[8]
Borowitz MJ(2009)Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia Blood 114 148-152
[9]
Le Beau MM(2016)Considerations and challenges for patients with refractory and relapsed acute myeloid leukaemia Leuk Res 47 149-160
[10]
Papaemmanuil E(2016)Association between DCK 35708 T>C variation and clinical outcomes of acute myeloid leukemia in South Chinese patients Pharmacogenomics. 17 1519-1531